Cogent Biosciences, Inc. Common Stock (COGT) is a publicly traded Healthcare sector company. As of May 20, 2026, COGT trades at $32.93 with a market cap of $5.36B and a P/E ratio of -15.19. COGT moved +5.44% today. Year to date, COGT is -3.90%; over the trailing twelve months it is +520.06%. Its 52-week range spans $3.72 to $43.73. Analyst consensus is strong buy with an average price target of $52.10. Rallies surfaces COGT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Cogent Biosciences, Inc. Common Stock (COGT) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. COGT moved +5.44% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $32.93 |
| Market Cap | $5.36B |
| P/E Ratio | -15.19 |
| EPS | $-2.16 |
| Dividend Yield | 0.00% |
| 52-Week High | $43.73 |
| 52-Week Low | $3.72 |
| Volume | 1.54M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-328.94M |
| Gross Margin | 0.00% |
11 analysts cover COGT: 0 strong buy, 9 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $52.10.